Macrophage Migration Inhibitory Factor (MIF) centrally regulates pulmonary immunity and lung diseases

The pulmonary immune system is a complex network crucial for defense against pathogens and environmental insults, yet its dysregulation contributes to numerous chronic lung diseases like COPD, asthma, and acute lung injury. Current therapeutic strategies often target broad inflammatory pathways, leading to systemic side effects or insufficient efficacy due to the intricate, multi-faceted nature of lung inflammation. A deeper understanding of central regulatory molecules that orchestrate these immune responses is vital for developing more precise and effective interventions. Macrophage Migration Inhibitory Factor (MIF) has emerged as a key pleiotropic cytokine, uniquely positioned to integrate diverse cellular and molecular signals within the lung microenvironment.

This comprehensive review synthesized existing literature to provide a systems biology perspective on the multifaceted roles of Macrophage Migration Inhibitory Factor (MIF) in pulmonary immunity and various lung diseases. The authors systematically analyzed how MIF integrates inflammatory signalling, redox control, and immune-stromal communication within the lung. They explored MIF's diverse functions, including its enzymatic (tautomerase) activity and its interactions with key receptors such as CD74, CXCR2, and CXCR4. The review aimed to map the complex network of MIF-mediated pathways, highlighting its involvement in both acute and chronic pulmonary pathologies, and to identify potential therapeutic targets based on this integrated understanding.

The review elucidated Macrophage Migration Inhibitory Factor (MIF) as a pivotal cytokine that transcends its initial characterization as a simple pro-inflammatory mediator, acting as a central hub in pulmonary immune networks. MIF integrates inflammatory signalling by activating pathways like NF-κB and MAPK, promoting the release of other pro-inflammatory cytokines such as TNF-α and IL-6. It also plays a critical role in redox control, influencing cellular responses to oxidative stress, which is a hallmark of many chronic lung conditions. Furthermore, MIF mediates immune-stromal communication through its interactions with receptors like CD74, CXCR2, and CXCR4, affecting cell proliferation, migration, and survival of various immune and structural cells in the lung. Its tautomerase activity is crucial for certain biological functions, including its ability to regulate cell cycle progression and apoptosis. The review highlighted MIF's significant involvement in the pathogenesis of diseases such as Chronic Obstructive Pulmonary Disease (COPD), asthma, acute respiratory distress syndrome (ARDS), and pulmonary fibrosis, where its dysregulation contributes to persistent inflammation, tissue remodeling, and impaired resolution of injury. > MIF's pleiotropic nature allows it to modulate both innate and adaptive immune responses, making it a critical determinant of disease progression and severity in the lung.